Search

Your search keyword '"Osaka, Takafumi"' showing total 39 results
Start Over Author "Osaka, Takafumi"
39 results on '"Osaka, Takafumi"'

1. Associations between thyroid hormones and appendicular skeletal muscle index, and hand grip strength in people with diabetes: The KAMOGAWA-A study

Author

Hata, Shinnosuke, Okada, Hiroshi, Minamida, Megumi, Hironaka, Junya, Hasegawa, Yuka, Kondo, Yuriko, Nakajima, Hanako, Kitagawa, Nobuko, Okamura, Takuro, Hashimoto, Yoshitaka, Osaka, Takafumi, Kitagawa, Noriyuki, Majima, Saori, Senmaru, Takafumi, Ushigome, Emi, Nakanishi, Naoko, Asano, Mai, Hamaguchi, Masahide, and Fukui, Michiaki

Published
2024
Full Text
View/download PDF

4. Relationship between diabetes diet-related quality of life and dietary fiber intake among people with type 2 diabetes: a cross-sectional study

Author

Takahashi, Fuyuko, primary, Hashimoto, Yoshitaka, additional, Kaji, Ayumi, additional, Sakai, Ryosuke, additional, Kawate, Yuka, additional, Kondo, Yuriko, additional, Okamura, Takuro, additional, Nakanishi, Naoko, additional, Majima, Saori, additional, Osaka, Takafumi, additional, Okada, Hiroshi, additional, Senmaru, Takafumi, additional, Ushigome, Emi, additional, Asano, Mai, additional, Hamaguchi, Masahide, additional, Yamazaki, Masahiro, additional, Sato, Eiko, additional, and Fukui, Michiaki, additional

Published
2024
Full Text
View/download PDF

5. Reasons for Discontinuing Treatment with Sodium-Glucose Cotransporter 2 Inhibitors in Patients with Diabetes in Real-World Settings: The KAMOGAWA-A Study

Author

Saijo, Yuto, primary, Okada, Hiroshi, additional, Hata, Shinnosuke, additional, Nakajima, Hanako, additional, Kitagawa, Nobuko, additional, Okamura, Takuro, additional, Osaka, Takafumi, additional, Kitagawa, Noriyuki, additional, Majima, Saori, additional, Senmaru, Takafumi, additional, Ushigome, Emi, additional, Nakanishi, Naoko, additional, Hamaguchi, Masahide, additional, and Fukui, Michiaki, additional

Published
2023
Full Text
View/download PDF

8. The Association of Salt Intake and Non-alcoholic Fatty Liver Disease in People With Type 2 Diabetes: A Cross-Sectional Study

Author

Takahashi, Fuyuko, primary, Hashimoto, Yoshitaka, additional, Kaji, Ayumi, additional, Sakai, Ryosuke, additional, Kawate, Yuka, additional, Okamura, Takuro, additional, Kitagawa, Noriyuki, additional, Okada, Hiroshi, additional, Nakanishi, Naoko, additional, Majima, Saori, additional, Osaka, Takafumi, additional, Senmaru, Takafumi, additional, Ushigome, Emi, additional, Hamaguchi, Masahide, additional, and Fukui, Michiaki, additional

Published
2022
Full Text
View/download PDF

9. Impact of Eating Speed on Muscle Mass in Older Patients With Type 2 Diabetes: A Prospective Study of KAMOGAWA–DM Cohort

Author

Kobayashi, Genki, primary, Hashimoto, Yoshitaka, additional, Takahashi, Fuyuko, additional, Kaji, Ayumi, additional, Sakai, Ryosuke, additional, Okamura, Takuro, additional, Okada, Hiroshi, additional, Kitagawa, Noriyuki, additional, Nakanishi, Naoko, additional, Majima, Saori, additional, Osaka, Takafumi, additional, Senmaru, Takafumi, additional, Ushigome, Emi, additional, Asano, Mai, additional, Hamaguchi, Masahide, additional, Yamazaki, Masahiro, additional, and Fukui, Michiaki, additional

Published
2022
Full Text
View/download PDF

10. Relationship between serum creatinine to cystatin C ratio and subclinical atherosclerosis in patients with type 2 diabetes

Author

Hashimoto, Yoshitaka, primary, Takahashi, Fuyuko, additional, Okamura, Takuro, additional, Osaka, Takafumi, additional, Okada, Hiroshi, additional, Senmaru, Takafumi, additional, Majima, Saori, additional, Ushigome, Emi, additional, Nakanishi, Naoko, additional, Asano, Mai, additional, Hamaguchi, Masahide, additional, Yamazaki, Masahiro, additional, and Fukui, Michiaki, additional

Published
2022
Full Text
View/download PDF

12. Dietary Fiber Intake Is Related to Skeletal Muscle Mass, Body Fat Mass, and Muscle-to-Fat Ratio Among People With Type 2 Diabetes: A Cross-Sectional Study

Author

Takahashi, Fuyuko, primary, Hashimoto, Yoshitaka, additional, Kaji, Ayumi, additional, Sakai, Ryosuke, additional, Kawate, Yuka, additional, Okamura, Takuro, additional, Okada, Hiroshi, additional, Kitagawa, Noriyuki, additional, Nakanishi, Naoko, additional, Majima, Saori, additional, Osaka, Takafumi, additional, Senmaru, Takafumi, additional, Ushigome, Emi, additional, Asano, Mai, additional, Hamaguchi, Masahide, additional, Yamazaki, Masahiro, additional, and Fukui, Michiaki, additional

Published
2022
Full Text
View/download PDF

14. Relative low muscle mass and muscle strength is associated with the prevalence of metabolic syndrome in patients with type 2 diabetes

Author

Takegami, Maya, primary, Hashimoto, Yoshitaka, additional, Hamaguchi, Masahide, additional, Kaji, Ayumi, additional, Sakai, Ryosuke, additional, Okamura, Takuro, additional, Kitagawa, Noriyuki, additional, Osaka, Takafumi, additional, Okada, Hiroshi, additional, Nakanishi, Naoko, additional, Majima, Saori, additional, Senmaru, Takafumi, additional, Ushigome, Emi, additional, Asano, Mai, additional, Yamazaki, Masahiro, additional, and Fukui, Michiaki, additional

Published
2022
Full Text
View/download PDF

15. Effects of probiotic Bifidobacterium bifidum G9‐1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open‐label, single‐arm, exploratory research trial

Author

Hata, Shinnosuke, primary, Nakajima, Hanako, additional, Hashimoto, Yoshitaka, additional, Miyoshi, Tomoki, additional, Hosomi, Yukako, additional, Okamura, Takuro, additional, Majima, Saori, additional, Nakanishi, Naoko, additional, Senmaru, Takafumi, additional, Osaka, Takafumi, additional, Okada, Hiroshi, additional, Ushigome, Emi, additional, Hamaguchi, Masahide, additional, Asano, Mai, additional, Yamazaki, Masahiro, additional, and Fukui, Michiaki, additional

Published
2021
Full Text
View/download PDF

16. Multicenter, Open Label, Randomized Controlled Superiority Trial for Availability to Reduce Nocturnal Urination Frequency: Study Protocol for a TOP-STAR Study.

Author

Nakajima, Hanako, Okada, Hiroshi, Kogure, Akinori, Osaka, Takafumi, Tsutsumi, Takeshi, Tanaka, Toru, Hasegawa, Goji, Mogami, Shinichi, Mitsuhashi, Kazuteru, Kitagawa, Noriyuki, Hashimoto, Yoshitaka, Yano, Miho, Tanaka, Muhei, Kitamura, Akane, Ishii, Michiyo, Nakamura, Naoto, Kishi, Akio, Ushigome, Emi, Hamaguchi, Masahide, and Fukui, Michiaki

Published
2022
Full Text
View/download PDF

17. Development of application to automatically calculate mean amplitude of glycaemic excursions using intermittently scanned continuous glucose monitoring data

Author

Kitae, Aya, primary, Kimura, Tetsuya, additional, Munekawa, Chihiro, additional, Hosomi, Yukako, additional, Osaka, Takafumi, additional, Kitagawa, Noriyuki, additional, Ushigome, Emi, additional, Yamazaki, Masahiro, additional, Hamaguchi, Masahide, additional, and Fukui, Michiaki, additional

Published
2021
Full Text
View/download PDF

18. Effect of coronavirus disease 2019 pandemic on the lifestyle and glycemic control in patients with type 2 diabetes: a cross-section and retrospective cohort study

Author

Munekawa, Chihiro, primary, Hosomi, Yukako, additional, Hashimoto, Yoshitaka, additional, Okamura, Takuro, additional, Takahashi, Fuyuko, additional, Kawano, Rena, additional, Nakajima, Hanako, additional, Osaka, Takafumi, additional, Okada, Hiroshi, additional, Majima, Saori, additional, Senmaru, Takafumi, additional, Nakanishi, Naoko, additional, Ushigome, Emi, additional, Hamaguchi, Masahide, additional, Yamazaki, Masahiro, additional, and Fukui, Michiaki, additional

Published
2021
Full Text
View/download PDF

20. Intake of sucrose affects gut dysbiosis in patients with type 2 diabetes

Author

Hashimoto, Yoshitaka, primary, Hamaguchi, Masahide, additional, Kaji, Ayumi, additional, Sakai, Ryosuke, additional, Osaka, Takafumi, additional, Inoue, Ryo, additional, Kashiwagi, Saori, additional, Mizushima, Katsura, additional, Uchiyama, Kazuhiko, additional, Takagi, Tomohisa, additional, Naito, Yuji, additional, and Fukui, Michiaki, additional

Published
2020
Full Text
View/download PDF

22. A Pilot Study on the Effect of Anti-Thrombopoietin Antibody on Platelet Count in Patients with Type 2 Diabetes

Author

Fukuda, Takuya, primary, Hamaguchi, Masahide, additional, Osaka, Takafumi, additional, Hashimoto, Yoshitaka, additional, Ushigome, Emi, additional, Asano, Mai, additional, Yamazaki, Masahiro, additional, Fukuda, Eriko, additional, Yamaguchi, Kei, additional, Ogawa, Koji, additional, Goshima, Naoki, additional, and Fukui, Michiaki, additional

Published
2020
Full Text
View/download PDF

25. Effect of probiotics, Bifidobacterium bifidum G9-1, on gastrointestinal symptoms in patients with type 2 diabetes mellitus: study protocol for open-label, single-arm, exploratory research trial (Big STAR study)

Author

Hashimoto, Yoshitaka, primary, Nakajima, Hanako, additional, Hata, Shinnosuke, additional, Miyoshi, Tomoki, additional, Hosomi, Yukako, additional, Majima, Saori, additional, Nakanishi, Naoko, additional, Senmaru, Takafumi, additional, Osaka, Takafumi, additional, Okada, Hiroshi, additional, Ushigome, Emi, additional, Hamaguchi, Masahide, additional, Asano, Mai, additional, Yamazaki, Masahiro, additional, and Fukui, Michiaki, additional

Published
2020
Full Text
View/download PDF

26. Reduced dietary omega-3 fatty acids intake is associated with sarcopenia in elderly patients with type 2 diabetes: a cross-sectional study of KAMOGAWA-DM cohort study

Author

Okamura, Takuro, primary, Hashimoto, Yoshitaka, additional, Miki, Akane, additional, Kaji, Ayumi, additional, Sakai, Ryosuke, additional, Iwai, Keiko, additional, Osaka, Takafumi, additional, Ushigome, Emi, additional, Hamaguchi, Masahide, additional, Yamazaki, Masahiro, additional, and Fukui, Michiaki, additional

Published
2020
Full Text
View/download PDF

27. Effects of probiotic Bifidobacterium bifidum G9‐1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open‐label, single‐arm, exploratory research trial.

Author

Hata, Shinnosuke, Nakajima, Hanako, Hashimoto, Yoshitaka, Miyoshi, Tomoki, Hosomi, Yukako, Okamura, Takuro, Majima, Saori, Nakanishi, Naoko, Senmaru, Takafumi, Osaka, Takafumi, Okada, Hiroshi, Ushigome, Emi, Hamaguchi, Masahide, Asano, Mai, Yamazaki, Masahiro, and Fukui, Michiaki

Subjects
TYPE 2 diabetes, BIFIDOBACTERIUM bifidum, PROBIOTICS, GLYCOSYLATED hemoglobin, METFORMIN, GUT microbiome
Abstract

Aims/Introduction: Metformin is associated with the risk of gastrointestinal complications, and probiotic Bifidobacterium bifidum G9‐1 (BBG9‐1) can improve the symptoms of diarrhea. This study aimed to clarify the effects of probiotic BBG9‐1 on the gastrointestinal symptoms of type 2 diabetes mellitus patients using metformin. Materials and methods: In this open‐label single‐arm exploratory study, 40 patients (mean age 64.0 ± 9.4 years) were given probiotic BBG9‐1 for 10 weeks. Changes in the gastrointestinal symptom rating scale total score, which was the primary end‐point, gastrointestinal symptom rating scale subscale scores, glycated hemoglobin levels and gut microbiota after the administration of probiotic BBG9‐1 were evaluated by the Student's t‐test. Results: The gastrointestinal symptom rating scale total score significantly improved (from 2.02 ± 0.51 to 1.59 ± 0.43, change, −0.43 ± 0.49, P < 0.001). Furthermore, all gastrointestinal symptom rating scale subscale scores, including diarrhea (from 2.32 ± 1.14 to 1.89 ± 0.99, change, −0.42 ± 0.95, P = 0.007) and constipation (from 3.00 ± 1.16 to 2.20 ± 1.07, change, −0.80 ± 1.19, P < 0.001), scores also significantly improved. However, the glycated hemoglobin levels did not change (from 7.0 ± 0.7 to 7.0 ± 0.6%, change, 0.0 ± 0.4, P = 0.91). The relative abundance of the genus Sutterella decreased by the use of probiotic BBG9‐1 (from 0.011 ± 0.009 to 0.008 ± 0.006, change, −0.003 ± 0.006, P = 0.002). Conclusions: Type 2 diabetes mellitus patients treated with metformin showed significant improvement in all gastrointestinal symptom rating scores after using probiotic BBG9‐1 without changing the glucose control. This study showed the potential usefulness of probiotic BBG9‐1 for improving gastrointestinal symptoms, including constipation and diarrhea, in type 2 diabetes mellitus patients treated with metformin. [ABSTRACT FROM AUTHOR]

Published
2022
Full Text
View/download PDF

31. High brain natriuretic peptide is associated with sarcopenia in patients with type 2 diabetes: a cross-sectional study of KAMOGAWA-DM cohort study

Author

Okamura, Takuro, primary, Hashimoto, Yoshitaka, additional, Miki, Akane, additional, Kaji, Ayumi, additional, Sakai, Ryosuke, additional, Iwai, Keiko, additional, Osaka, Takafumi, additional, Kitagawa, Noriyuki, additional, Ushigome, Emi, additional, Hamaguchi, Masahide, additional, Asano, Mai, additional, Yamazaki, Masahiro, additional, and Fukui, Michiaki, additional

Published
2019
Full Text
View/download PDF

33. Asymptomatic postprandial hypotension in patients with diabetes: The KAMOGAWA‐HBP study.

Author

Kitae, Aya, Ushigome, Emi, Hashimoto, Yoshitaka, Majima, Saori, Senmaru, Takafumi, Osaka, Takafumi, Okada, Hiroshi, Hamaguchi, Masahide, Asano, Mai, Yamazaki, Masahiro, and Fukui, Michiaki

Subjects
SYSTOLIC blood pressure, PEOPLE with diabetes, HYPOTENSION, HYPERTENSION, LOGISTIC regression analysis
Abstract

Aims/Introduction: Postprandial hypotension (PPH) refers to a decrease in systolic blood pressure by ≥20 or to <90 mmHg from baseline ≥100 mmHg within 2 h of a meal. Previous studies have reported an association between diabetes and PPH; however, the characteristics of PPH in patients with diabetes remain unclear. Materials and Methods: We recruited patients with diabetes who regularly attended the diabetes outpatient clinic. Participants were instructed to carry out three sets of blood pressure measurements at six time points: just before and right after, and 30, 60, 90 and 120 min after their main meal of the day. Data on PPH symptoms were collected during an interview. To investigate the relationships between explanatory variables, PPH and associated symptoms, we carried out multiple logistic regression analyses. Results: We analyzed data from 300 participants. There were 150 (50.0%) participants with PPH. Systolic blood pressure before a meal was significantly associated with PPH (odds ratio [OR] 1.56, 95% confidence interval [CI] 1.30–1.86, P < 0.001), after adjusting for covariates. Furthermore, age (OR 1.08, 95% CI 1.01–1.16, P = 0.027), hemoglobin A1c level (OR 2.39, 95% CI 1.01–5.64, P = 0.030) and coefficients of variation of R‐R intervals (OR 0.79, 95% CI 0.65–0.97, P = 0.032) were significantly associated with asymptomatic PPH. Conclusions: Half of the present study outpatients with diabetes had PPH. High systolic blood pressure before a meal was significantly associated with the risk of PPH. Older adults and patients with higher levels of hemoglobin A1c or an autonomic dysfunction might have difficulties recognizing symptoms of PPH. [ABSTRACT FROM AUTHOR]

Published
2021
Full Text
View/download PDF

36. Shortage of energy intake rather than protein intake is associated with sarcopenia in elderly patients with type 2 diabetes: A cross‐sectional study of the KAMOGAWA‐DM cohort.

Author

Okamura, Takuro, Miki, Akane, Hashimoto, Yoshitaka, Kaji, Ayumi, Sakai, Ryosuke, Osaka, Takafumi, Hamaguchi, Masahide, Yamazaki, Masahiro, and Fukui, Michiaki

Subjects
TYPE 2 diabetes, ENERGY shortages, OLDER patients, BODY composition, MUSCLE mass
Abstract

Copyright of Journal of Diabetes is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Published
2019
Full Text
View/download PDF

39. Multicenter, open label, randomized controlled superiority trial for availability to reduce nocturnal urination frequency: The TOP‐STAR study.

Author

Nakajima, Hanako, Okada, Hiroshi, Kogure, Akinori, Osaka, Takafumi, Tsutsumi, Takeshi, Onishi, Masayoshi, Mitsuhashi, Kazuteru, Kitagawa, Noriyuki, Mogami, Shinichi, Kitamura, Akane, Ishii, Michiyo, Nakamura, Naoto, Kishi, Akio, Eiko, Sato, Hamaguchi, Masahide, and Fukui, Michiaki

Subjects
*TYPE 2 diabetes, *NOCTURIA, *SODIUM-glucose cotransporter 2 inhibitors, *URINATION, *QUALITY of life
Abstract

ABSTRACT Aim Materials and Methods Results Conclusions Nocturia impairs the quality of life in patients with type 2 diabetes mellitus. Although sodium glucose co‐transporter 2 inhibitors (SGLT2i) such as tofogliflozin increase urine volume, their impact on nocturia, in conjunction with dietary salt restriction, is less clear.This multicenter, open‐label, randomized, parallel‐group trial included 80 subjects with type 2 diabetes and nocturia. The patients were divided into two groups: one receiving tofogliflozin, the shortest half‐life, without salt restriction, and the other receiving both tofogliflozin and dietary salt restriction. The primary endpoint was nocturia frequency at 12 weeks. The secondary outcomes included changes in daytime urination frequency, urine volume, and home blood pressure.At 12 weeks, there were no significant differences in nocturia changes between both groups. Nocturia frequency did not change in the tofogliflozin without salt restriction group from 1.5 ± 0.8 to 1.3 ± 1.1 times per night (P = 0.297), and significantly decreased from 1.6 ± 1.0 to 1.3 ± 0.7 times per night in the tofogliflozin and dietary salt restriction group (P = 0.049). There was a trend toward increased urine volume and frequency during the daytime in the group with salt restriction, indicating a time‐shift effect of the short half‐life tofogliflozin and salt restriction on urinary time.The frequency of nocturia after tofogliflozin did not increase. Tofogliflozin reduced nocturia when combined with salt restriction. Furthermore, daytime urine volume and frequency showed an increasing trend, suggesting a shift in urine production to daytime hours due to the short half‐life of tofogliflozin. Dietary modifications can enhance the therapeutic benefits of tofogliflozin in managing nocturia in people with type 2 diabetes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results